Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in a dozen other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, Virginia and Wisconsin
PMID: 10 HuttaschMRodenMKahlS
This review examines its effectiveness, costs, and potential drawbacks to help you make an informed decision
DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes
This effect helps you feel fuller for longer, slows down the emptying of your stomach and so reduces your appetite
Recommended Dosage Guidelines Determining the appropriate dosage of cagrlintide when used alongside tirzepatide requires careful consideration of individual patient factors, including tolerance, response, and any side effects